I read your article with great interest, having just blogged about a supposed provision in Sarbanes Oxley which makes it possible for pharma execs, for example, to be held personally liable if they knowingly concealed, colluded, or covered up side effects of a drug.

As one academic from UK told me “It’s hard to included a 20 year sentence into the marketing budget.”

This is a real question since documents exist showing collusion and conflicts of interest with pharma execs, FDA officials and others. I would be interested in your opinions on whether this is a legitimate possibility.

Many thanks for your fine work.

Kevin P. Miller